The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Somatostatin analogues stop your body from making too many hormones. They can reduce the symptoms of carcinoid syndrome and may slow down tumour growth.
Somatostatin is a protein made naturally in the body. It is made by: a gland in the brain (hypothalamus), the stomach, the pancreas and the bowel. Somatostatin can slow down hormone production, including many of the gut hormones, slows down the emptying of the stomach and bowel, controls the release of hormones made by the pancreas, including insulin and, slows down or stops the release of growth hormones. Rise in the research and development and launch of novel drug therapies are the factors driving the growth of somatostatin analogs over the forecast period.
The global Somatostatin Analogs market was valued at US$ 4500.3 million in 2020 and is expected to reach US$ 6543.2 million by the end of 2027, growing at a CAGR of 5.0% during 2021-2027.
This report focuses on Somatostatin Analogs volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Somatostatin Analogs market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Somatostatin Analogs Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
- Octreotide
- Lanreotide
- Pasireotide
Segment by Application
- Acromegaly
- Carcinoid Syndrome
- Neuroendocrine Tumor
- Cushing Syndrome
- Others
By Region
- North America (United States, Canada, Mexico)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, Other Regions)
- Europe (Germany, U.K., France, Italy, Russia, Rest of Europe)
- South America (Brazil, Argentina, Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, U.A.E., South Africa, Other Regions)
By Company
- Novartis
- Peptron
- Chiasma
- Ipsen Biopharmaceutical
Scope of the Somatostatin Analogs Market Report
|
Report Metric |
Details |
|
Report Name |
Somatostatin Analogs Market |
|
Market size in 2020 |
US$ 4500.3 Million |
|
The revenue forecast in 2027 |
US$ 6543.2 Million |
|
Growth Rate |
CAGR of 5.0% from 2021 to 2027 |
|
Market size available for years |
2020-2027 |
|
Forecast units |
Value (USD) & Volume (Units) |
|
Segments covered |
Types, End-User / Applications, Companies, and Region |
|
Report coverage |
Revenue & volume forecast, company share, competitive landscape, growth factors, and trends |
|
Geographic regions covered |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
Index
1 Somatostatin Analogs Market Overview
1.1 Product Overview and Scope of Somatostatin Analogs
1.2 Somatostatin Analogs Segment by Type
1.2.1 Global Somatostatin Analogs Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Octreotide
1.2.3 Lanreotide
1.2.4 Pasireotide
1.3 Somatostatin Analogs Segment by Application
1.3.1 Global Somatostatin Analogs Sales Comparison by Application: (2021-2027)
1.3.2 Acromegaly
1.3.3 Carcinoid Syndrome
1.3.4 Neuroendocrine Tumor
1.3.5 Cushing Syndrome
1.3.6 Others
1.4 Global Somatostatin Analogs Market Size Estimates and Forecasts
1.4.1 Global Somatostatin Analogs Revenue 2016-2027
1.4.2 Global Somatostatin Analogs Sales 2016-2027
1.4.3 Somatostatin Analogs Market Size by Region: 2016 Versus 2021 Versus 2027
2 Somatostatin Analogs Market Competition by Manufacturers
2.1 Global Somatostatin Analogs Sales Market Share by Manufacturers (2016-2021)
2.2 Global Somatostatin Analogs Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Somatostatin Analogs Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Somatostatin Analogs Manufacturing Sites, Area Served, Product Type
2.5 Somatostatin Analogs Market Competitive Situation and Trends
2.5.1 Somatostatin Analogs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Somatostatin Analogs Players Market Share by Revenue
2.5.3 Global Somatostatin Analogs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Somatostatin Analogs Retrospective Market Scenario by Region
3.1 Global Somatostatin Analogs Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Somatostatin Analogs Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Somatostatin Analogs Market Facts & Figures by Country
3.3.1 North America Somatostatin Analogs Sales by Country
3.3.2 North America Somatostatin Analogs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Somatostatin Analogs Market Facts & Figures by Country
3.4.1 Europe Somatostatin Analogs Sales by Country
3.4.2 Europe Somatostatin Analogs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Somatostatin Analogs Market Facts & Figures by Region
3.5.1 Asia Pacific Somatostatin Analogs Sales by Region
3.5.2 Asia Pacific Somatostatin Analogs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Somatostatin Analogs Market Facts & Figures by Country
3.6.1 Latin America Somatostatin Analogs Sales by Country
3.6.2 Latin America Somatostatin Analogs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Somatostatin Analogs Market Facts & Figures by Country
3.7.1 Middle East and Africa Somatostatin Analogs Sales by Country
3.7.2 Middle East and Africa Somatostatin Analogs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Somatostatin Analogs Historic Market Analysis by Type
4.1 Global Somatostatin Analogs Sales Market Share by Type (2016-2021)
4.2 Global Somatostatin Analogs Revenue Market Share by Type (2016-2021)
4.3 Global Somatostatin Analogs Price by Type (2016-2021)
5 Global Somatostatin Analogs Historic Market Analysis by Application
5.1 Global Somatostatin Analogs Sales Market Share by Application (2016-2021)
5.2 Global Somatostatin Analogs Revenue Market Share by Application (2016-2021)
5.3 Global Somatostatin Analogs Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Corporation Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Somatostatin Analogs Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Novartis Somatostatin Analogs Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Peptron
6.2.1 Peptron Corporation Information
6.2.2 Peptron Description and Business Overview
6.2.3 Peptron Somatostatin Analogs Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Peptron Somatostatin Analogs Product Portfolio
6.2.5 Peptron Recent Developments/Updates
6.3 Chiasma
6.3.1 Chiasma Corporation Information
6.3.2 Chiasma Description and Business Overview
6.3.3 Chiasma Somatostatin Analogs Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Chiasma Somatostatin Analogs Product Portfolio
6.3.5 Chiasma Recent Developments/Updates
6.4 Ipsen Biopharmaceutical
6.4.1 Ipsen Biopharmaceutical Corporation Information
6.4.2 Ipsen Biopharmaceutical Description and Business Overview
6.4.3 Ipsen Biopharmaceutical Somatostatin Analogs Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Ipsen Biopharmaceutical Somatostatin Analogs Product Portfolio
6.4.5 Ipsen Biopharmaceutical Recent Developments/Updates
7 Somatostatin Analogs Manufacturing Cost Analysis
7.1 Somatostatin Analogs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Somatostatin Analogs
7.4 Somatostatin Analogs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Somatostatin Analogs Distributors List
8.3 Somatostatin Analogs Customers
9 Somatostatin Analogs Market Dynamics
9.1 Somatostatin Analogs Industry Trends
9.2 Somatostatin Analogs Growth Drivers
9.3 Somatostatin Analogs Market Challenges
9.4 Somatostatin Analogs Market Restraints
10 Global Market Forecast
10.1 Somatostatin Analogs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Somatostatin Analogs by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Somatostatin Analogs by Type (2022-2027)
10.2 Somatostatin Analogs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Somatostatin Analogs by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Somatostatin Analogs by Application (2022-2027)
10.3 Somatostatin Analogs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Somatostatin Analogs by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Somatostatin Analogs by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
List of Tables
Table 1. Global Somatostatin Analogs Sales (K MT) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Somatostatin Analogs Sales (K MT) Comparison by Application (2021-2027)
Table 3. Global Somatostatin Analogs Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Somatostatin Analogs Covered in This Study
Table 5. Global Somatostatin Analogs Sales (K MT) of Key Manufacturers (2016-2021)
Table 6. Global Somatostatin Analogs Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Somatostatin Analogs Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Somatostatin Analogs Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Somatostatin Analogs Average Price (USD/MT) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Somatostatin Analogs Manufacturing Sites and Area Served
Table 11. Manufacturers Somatostatin Analogs Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Somatostatin Analogs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Somatostatin Analogs as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Somatostatin Analogs Sales by Region (2016-2021) & (K MT)
Table 16. Global Somatostatin Analogs Sales Market Share by Region (2016-2021)
Table 17. Global Somatostatin Analogs Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Somatostatin Analogs Sales by Country (2016-2021) & (K MT)
Table 19. North America Somatostatin Analogs Sales Market Share by Country (2016-2021)
Table 20. North America Somatostatin Analogs Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Somatostatin Analogs Revenue Market Share by Country (2016-2021)
Table 22. Europe Somatostatin Analogs Sales by Country (2016-2021) & (K MT)
Table 23. Europe Somatostatin Analogs Sales Market Share by Country (2016-2021)
Table 24. Europe Somatostatin Analogs Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Somatostatin Analogs Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Somatostatin Analogs Sales by Region (2016-2021) & (K MT)
Table 27. Asia Pacific Somatostatin Analogs Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Somatostatin Analogs Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Somatostatin Analogs Revenue Market Share by Region (2016-2021)
Table 30. Latin America Somatostatin Analogs Sales by Country (2016-2021) & (K MT)
Table 31. Latin America Somatostatin Analogs Sales Market Share by Country (2016-2021)
Table 32. Latin America Somatostatin Analogs Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Somatostatin Analogs Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Somatostatin Analogs Sales by Country (2016-2021) & (K MT)
Table 35. Middle East and Africa Somatostatin Analogs Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Somatostatin Analogs Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Somatostatin Analogs Revenue Market Share by Country (2016-2021)
Table 38. Global Somatostatin Analogs Sales (K MT) by Type (2016-2021)
Table 39. Global Somatostatin Analogs Sales Market Share by Type (2016-2021)
Table 40. Global Somatostatin Analogs Revenue (Million US$) by Type (2016-2021)
Table 41. Global Somatostatin Analogs Revenue Share by Type (2016-2021)
Table 42. Global Somatostatin Analogs Price (USD/MT) by Type (2016-2021)
Table 43. Global Somatostatin Analogs Sales (K MT) by Application (2016-2021)
Table 44. Global Somatostatin Analogs Sales Market Share by Application (2016-2021)
Table 45. Global Somatostatin Analogs Revenue (Million US$) by Application (2016-2021)
Table 46. Global Somatostatin Analogs Revenue Share by Application (2016-2021)
Table 47. Global Somatostatin Analogs Price (USD/MT) by Application (2016-2021)
Table 48. Novartis Corporation Information
Table 49. Novartis Description and Business Overview
Table 50. Novartis Somatostatin Analogs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 51. Novartis Somatostatin Analogs Product
Table 52. Novartis Recent Developments/Updates
Table 53. Peptron Corporation Information
Table 54. Peptron Description and Business Overview
Table 55. Peptron Somatostatin Analogs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 56. Peptron Somatostatin Analogs Product
Table 57. Peptron Recent Developments/Updates
Table 58. Chiasma Corporation Information
Table 59. Chiasma Description and Business Overview
Table 60. Chiasma Somatostatin Analogs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 61. Chiasma Somatostatin Analogs Product
Table 62. Chiasma Recent Developments/Updates
Table 63. Ipsen Biopharmaceutical Corporation Information
Table 64. Ipsen Biopharmaceutical Description and Business Overview
Table 65. Ipsen Biopharmaceutical Somatostatin Analogs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 66. Ipsen Biopharmaceutical Somatostatin Analogs Product
Table 67. Ipsen Biopharmaceutical Recent Developments/Updates
Table 68. Production Base and Market Concentration Rate of Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Somatostatin Analogs Distributors List
Table 71. Somatostatin Analogs Customers List
Table 72. Somatostatin Analogs Market Trends
Table 73. Somatostatin Analogs Growth Drivers
Table 74. Somatostatin Analogs Market Challenges
Table 75. Somatostatin Analogs Market Restraints
Table 76. Global Somatostatin Analogs Sales Forecast by Type (2022-2027) & (K MT)
Table 77. Global Somatostatin Analogs Sales Market Share Forecast by Type (2022-2027)
Table 78. Global Somatostatin Analogs Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 79. Global Somatostatin Analogs Revenue Market Share Forecast by Type (2022-2027)
Table 80. Global Somatostatin Analogs Sales Forecast by Application (2022-2027) & (K MT)
Table 81. Global Somatostatin Analogs Sales Market Share Forecast by Application (2022-2027)
Table 82. Global Somatostatin Analogs Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 83. Global Somatostatin Analogs Revenue Market Share Forecast by Application (2022-2027)
Table 84. Global Somatostatin Analogs Sales Forecast by Region (2022-2027) & (K MT)
Table 85. Global Somatostatin Analogs Sales Market Share Forecast by Region (2022-2027)
Table 86. Global Somatostatin Analogs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 87. Global Somatostatin Analogs Revenue Market Share Forecast by Region (2022-2027)
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Somatostatin Analogs
Figure 2. Global Somatostatin Analogs Market Share by Type in 2020 & 2027
Figure 3. Octreotide Product Picture
Figure 4. Lanreotide Product Picture
Figure 5. Pasireotide Product Picture
Figure 6. Global Somatostatin Analogs Market Share by Application in 2020 & 2027
Figure 7. Acromegaly
Figure 8. Carcinoid Syndrome
Figure 9. Neuroendocrine Tumor
Figure 10. Cushing Syndrome
Figure 11. Others
Figure 12. Global Somatostatin Analogs Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Somatostatin Analogs Market Size 2016-2027 (US$ Million)
Figure 14. Global Somatostatin Analogs Sales 2016-2027 (K MT)
Figure 15. Global Somatostatin Analogs Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 16. Somatostatin Analogs Sales Share by Manufacturers in 2020
Figure 17. Global Somatostatin Analogs Revenue Share by Manufacturers in 2020
Figure 18. The Global 5 and 10 Largest Somatostatin Analogs Players: Market Share by Revenue in 2020
Figure 19. Somatostatin Analogs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 20. Global Somatostatin Analogs Sales Market Share by Region (2016-2021)
Figure 21. Global Somatostatin Analogs Sales Market Share by Region in 2020
Figure 22. Global Somatostatin Analogs Revenue Market Share by Region (2016-2021)
Figure 23. Global Somatostatin Analogs Revenue Market Share by Region in 2020
Figure 24. U.S. Somatostatin Analogs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Canada Somatostatin Analogs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Germany Somatostatin Analogs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. France Somatostatin Analogs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. U.K. Somatostatin Analogs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Italy Somatostatin Analogs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Russia Somatostatin Analogs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. China Somatostatin Analogs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Japan Somatostatin Analogs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. South Korea Somatostatin Analogs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. India Somatostatin Analogs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Australia Somatostatin Analogs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Taiwan Somatostatin Analogs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Indonesia Somatostatin Analogs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Thailand Somatostatin Analogs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Malaysia Somatostatin Analogs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Philippines Somatostatin Analogs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Vietnam Somatostatin Analogs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Mexico Somatostatin Analogs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Brazil Somatostatin Analogs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Argentina Somatostatin Analogs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Turkey Somatostatin Analogs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Saudi Arabia Somatostatin Analogs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. U.A.E Somatostatin Analogs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Sales Market Share of Somatostatin Analogs by Type (2016-2021)
Figure 49. Sales Market Share of Somatostatin Analogs by Application (2016-2021)
Figure 50. Sales Market Share of Somatostatin Analogs by Application in 2020
Figure 51. Revenue Share of Somatostatin Analogs by Application (2016-2021)
Figure 52. Revenue Share of Somatostatin Analogs by Application in 2020
Figure 53. Manufacturing Cost Structure of Somatostatin Analogs
Figure 54. Manufacturing Process Analysis of Somatostatin Analogs
Figure 55. Somatostatin Analogs Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
